Evaluation of a hypertension medication therapy management program in patients with diabetes

2009 ◽  
Vol 49 (2) ◽  
pp. 164-170 ◽  
Author(s):  
Lourdes G. Planas ◽  
Kimberly M. Crosby ◽  
Kimberly D. Mitchell ◽  
Kevin C. Farmer
2015 ◽  
Vol 35 (11) ◽  
pp. e159-e163 ◽  
Author(s):  
Katie M. Theising ◽  
Traci L. Fritschle ◽  
Angelina M. Scholfield ◽  
Emily L. Hicks ◽  
Michelle L. Schymik

2013 ◽  
Vol 35 (4) ◽  
pp. 534-540 ◽  
Author(s):  
Ahmed M. Soliman ◽  
Angeline M. Carlson ◽  
Richard F. MacLehose ◽  
Amanda R. Brummel ◽  
Jon C. Schommer

2012 ◽  
Vol 52 (6) ◽  
pp. 768-776 ◽  
Author(s):  
Leslie A. Shimp ◽  
Suzan N. Kucukarslan ◽  
Jodie Elder ◽  
Tami Remington ◽  
Trisha Wells ◽  
...  

2017 ◽  
Vol 57 (1) ◽  
pp. 95-101.e1
Author(s):  
Audrey Umbreit ◽  
Emily Holm ◽  
Kelsey Gander ◽  
Kelsie Davis ◽  
Kristina Dittrich ◽  
...  

2007 ◽  
Vol 10 (3) ◽  
pp. A204-A205
Author(s):  
SA Miller ◽  
Y Mu ◽  
Y Lou ◽  
Z Huang ◽  
R Radzicki ◽  
...  

Pharmacy ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 137
Author(s):  
Maira Anna Deters ◽  
Emina Obarcanin ◽  
Holger Schwender ◽  
Stephanie Läer

Background: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. Methods: To formulate a hypothesis regarding the effect of these four pharmaceutical care components on glycemic control in patients with diabetes mellitus and the feasibility of these components in practice. Ten patients with type 2 diabetes were included in the case series and received medication therapy management over four months. Results: The four care components were feasible in everyday practice and could be implemented within one patient visit. The average visits were 49 and 28 min at the beginning and end of the study, respectively. The glycated hemoglobin values did not change over the study period, though the fasting blood glucose decreased from 142 to 120 mg/dl, and the number of unsolved drug-related problems decreased from 6.9 to 1.9 per patient by the study end. Conclusions: This case series supports the hypothesis that community pharmacists can implement structured pharmaceutical care in everyday pharmacy practice for patients with type 2 diabetes mellitus.


Sign in / Sign up

Export Citation Format

Share Document